🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Denmark / NCT05530174
Active, not recruiting Not applicable

Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With a Fracture

NCT05530174 · tracked via the Priya Life Science Denmark tracker
Sponsor
Soren Overgaard
Phase
Not applicable
Started
2022-09-01
Last updated
2025-03-24

Condition(s) studied

Fracture of HipTotal Hip ArthroplastyProsthetic-joint InfectionFracture Acetabular

Investigational drug(s) / intervention(s)

Antibiotic dosage practice

Antibiotic dosage practice: Patient inclusion starts day one, cross-over of departments from treatment A (single-dose) to B (multiple-dose) or vice versa after one year and end of inclusion happens after 2 years. All centers in Denmark use either Cloxacillin/Dicloxacillin, Cefuroxime or both drugs as standard prophylactic antibiotic practice for THA. In cases of cephalosporin allergy or general beta lactam allergy, the antibiotic clindamycin may be administered. In this trial, patients will be administered the standard prophylactic antibiotic practice of either single-dose (A) or multiple-doses (B) of antibiotics administered at each respective cluster that respective year. Both practices of dose administration for antibiotic prophylaxis (i.e. single- or multiple-dose) follow current standards of treatment and are based on present clinical practice guidelines.

Study summary

Aim: To compare the effect of one single dose versus multiple doses of prophylactic antibiotics administered within 24 hours, on the development of PJI after surgery in patients undergoing primary THA due to an acute fracture or sequelae of proximal femoral or acetabular fractures.

The study is designed as a cross-over, cluster randomized, non-inferiority trial. All Danish orthopedic surgery departments performing primary THA with the majority being within inclusion criteria will be involved: Based on national quality databases, two-year cohorts of approximately 2,000 primary THAs due to a fracture or sequelae to a fracture, conducted at all public and private orthopedic departments in Denmark, this includes 36 sites corresponding to a total of 39 departments.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All patients receiving a primary Total Hip Arthroplasty (THA) due to an acute- or sequelae of proximal femoral or acetabular fractures Exclusion Criteria: * Patients receiving a primary THA due to bone tumor or metastasis * Patients receiving a primary THA due to osteoarthritis and all reasons according to the Danish Hip Arthroplasty Register (DHR) except conditions mentioned in the inclusion criteria

Primary outcome measure(s)

Trial sites (36)

FacilityCityRegionStatus
Department of Orthopedic Surgery, Aabenraa and Sønderborg, Hospital of Southern Jutland Aabenraa Denmark
Capio Private Hospital, Aalborg Aalborg Denmark
Department of Orthopedic Surgery, Aalborg, Aalborg University Hospital Aalborg Denmark
Aleris Private Hospital, Aarhus Aarhus Denmark
Deaprtment of Orthopaedic Surgery, Aarhus University Hospital Aarhus Denmark
Capio Private Hospital, Aarhus Aarhus C Denmark
Capio Private Hospital, Gildhøj Brøndby Denmark
Department of Orthopedic Surgery and Traumatology, Bispebjerg, Copenhagen University Hospital - Bispebjerg and Frederiksberg Copenhagen NV Denmark
Adeas Private Hospital, Parken Copenhagen Ø Denmark
Department of Orthopedic Surgery, Esbjerg, Hospital of South West Jutland Esbjerg Denmark
Department of Orthopedic Surgery, Farsø, Aalborg University Hospital Farsø Denmark
CPH Private Hospital Farum Denmark
Department of Orthopedic Surgery, Frederikshavn, Aalborg University Hospital Frederikshavn Denmark
Department of Orthopedic Surgery, Grindsted, Hospital of South West Jutland Grindsted Denmark
Capio Private Hospital, Hellerup and Odense Hellerup Denmark
Department of Orthopaedic Surgery, Gentofte, Copenhagen University Hospital - Herlev and Gentofte Hellerup Denmark
Department of Orthopaedic Surgery, Herlev, Copenhagen University Hospital - Herlev and Gentofte Herlev Denmark
Department of Orthopedic Surgery, Gødstrup Regional Hospital Herning Denmark
Department of Orthopedic Surgery, Hillerød, Copenhagen University Hospital - North Zealand Hillerød Denmark
Department of Orthopedic Surgery, Copenhagen University Hospital - Holbæk Holbæk Denmark
Department of Orthopedic Surgery, Horsens Regional Hospital, Denmark Horsens Denmark
Department of Orthopedic Surgery, Hvidovre, Copenhagen University Hospital - Amager and Hvidovre Hvidovre Denmark
Acure Private Hospital Kongens Lyngby Denmark
Kollund Private Hospital, Kollund Kruså Denmark
Department of Orthopedic Surgery, Zealand University Hospital, Køge Køge Denmark
Department of Orthopedic Surgery, Copenahegn University Hospital - Nykøbing F. Nykøbing Falster Denmark
Department for Planned Orthopaedic Surgery, Næstved, Copenhagen University Hospital - Næstved, Slagelse and Ringsted Næstved Denmark
Department of Orthopedic Surgery and Traumatology, Odense University Hospital and Svendborg Hospital Odense Denmark
Deparmtent of Orthopedic Surgery, Randers Regional Hospital Randers Denmark
Aleris Private Hospital, Ringsted Ringsted Denmark
Department of Surgery, Copenhagen University Hospital - Bornholm Rønne Denmark
Center for Planned Surgery, Silkeborg Regional Hospital Silkeborg Denmark
Aleris Private Hospital, Søborg Søborg Denmark
Department of Orthopedics, Lillebaelt Hospital, Vejle Vejle Denmark
Mølholm Private Hospital, Vejle Vejle Denmark
Deparmtent of Orthopedic Sugery, Viborg Regional Hospital Viborg Denmark

More Soren Overgaard trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05530174 on ClinicalTrials.gov ↗ ← All trials in Denmark